Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erratum for the Research Article: "Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis". | Sci Adv | 2023 | 37948531 | PubTator, text mining | PubMed |
| Integrative single-cell RNA-seq analysis of vascularized cerebral organoids. | BMC Biol | 2023 | 37940920 | PubTator, text mining | PubMed |
| Structure and functions of Mer, an innate immune checkpoint. | Front Immunol | 2023 | 37936688 | PubTator, text mining | PubMed |
| Measuring patient satisfaction with four items: validity of the client satisfaction questionnaire 4 in an outpatient population. | BMC Psychiatry | 2023 | 37936112 | PubTator, text mining | PubMed |
| Expression and clinical association of MFG-E8 and TAM receptors in diabetic patients with different stages of microvascular complication: An experimental study. | Medicine (Baltimore) | 2023 | 37933040 | PubTator, text mining | PubMed |
| Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin. | Aging (Albany NY) | 2023 | 37925175 | PubTator, text mining | PubMed |
| Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37915617 | PubTator, text mining | PubMed |
| Development of covalent chemogenetic K2P channel activators. | bioRxiv | 2023 | 37905049 | PubTator, text mining | PubMed |
| Soluble TAM Receptor Tyrosine Kinases Correlate with Disease Severity and Predict the Early Responsiveness of Sublingual Immunotherapy in Allergic Rhinitis. | J Inflamm Res | 2023 | 37904786 | PubTator, text mining | PubMed |
| Identification of RECK as a protective prognostic indicator and a tumor suppressor through regulation of the ERK/MAPK signaling pathway in gastric cancer. | J Transl Med | 2023 | 37904179 | PubTator, text mining | PubMed |
| Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration. | Front Aging | 2023 | 37900152 | PubTator, text mining | PubMed |
| The universe of galectin-binding partners and their functions in health and disease. | J Biol Chem | 2023 | 37898403 | PubTator, text mining | PubMed |
| Exploring key determinants of health among individuals with serious mental Illness: qualitative insights from a first episode psychosis cohort, 20 years postdiagnosis. | BMC Psychiatry | 2023 | 37884979 | PubTator, text mining | PubMed |
| NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype. | Cell Commun Signal | 2023 | 37853467 | PubTator, text mining | PubMed |
| Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma. | BMC Med Genomics | 2023 | 37853449 | PubTator, text mining | PubMed |
| A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer. | Cancer Drug Resist | 2023 | 37842236 | PubTator, text mining | PubMed |
| Intervention of AXL in EGFR Signaling via Phosphorylation and Stabilization of MIG6 in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 37834326 | PubTator, text mining | PubMed |
| Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells. | Int J Mol Sci | 2023 | 37833934 | PubTator, text mining | PubMed |
| Don't eat me/eat me signals as a novel strategy in cancer immunotherapy. | Heliyon | 2023 | 37822610 | PubTator, text mining | PubMed |
| Lifestyle risk factors of self-reported fibromyalgia in the Norwegian Women and Cancer (NOWAC) study. | BMC Public Health | 2023 | 37821848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=13